News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Newer Antiplatelets Best Clopidogrel, Pitie-Salpetriere Hospital Study


8/26/2010 6:23:40 AM

MedPage Today -- Newer P2Y12 inhibitors reduce all-cause mortality compared with clopidogrel (Plavix), the older member of the class, a meta-analysis showed.

Read at MedPageToday

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES